Selling a Medical Practice: What Physician Owners Should Understand

Medical practices sell to hospital systems, private equity backed platforms, and other physicians, with value driven by provider capacity beyond the owner, referral durability, payer mix, and compliance standing. Healthcare transactions carry regulatory requirements, including fraud-and-abuse and corporate practice rules, that make specialized healthcare counsel essential from the start.

A medical practice sale is a business transaction wrapped in a regulatory environment that most business advice ignores. Physician owners need both halves of the picture.

The buyer landscape

Three buyer families dominate. Hospital and health system acquirers buy practices for referral alignment and network strategy, and their deals often convert the physician into employment. Private equity backed platforms, typically structured through management services organizations, have consolidated heavily across specialties, dermatology, ophthalmology, orthopedics, primary care among them, a movement extensively documented in health policy research and the trade press; their offers frequently include rollover equity and multi-year practice commitments, close cousins of the DSO structures described in our dental article. And physician buyers, individuals or groups, remain the traditional path, especially for primary care and smaller practices.

As with dentistry, the structural point matters more than the headline: sales to institutional buyers usually purchase the physician's future working years along with the practice, and should be evaluated with the personal-readiness lens this series applies to every exit.

What buyers evaluate

The universal drivers apply with clinical accents. Provider capacity beyond the selling physician, employed physicians, advanced practice providers, determines whether the practice is a business or a personal clinical income stream. Referral relationships and their durability under new ownership get tested in diligence. Payer mix, contract rates, and the revenue cycle's health are examined line by line. And compliance standing, billing and coding accuracy, licensure, documentation, functions as a gate: problems here do not discount a deal so much as end it, since buyers inherit regulatory exposure.

The regulatory layer that changes everything

Healthcare transactions run through rules that ordinary business sales never meet: federal fraud-and-abuse laws that constrain how deals and post-sale compensation can be structured, state corporate practice of medicine doctrines that dictate who may own clinical entities and force the MSO structures buyers use, patient record and privacy obligations governing the transition, and payer contract and enrollment mechanics that determine when the buyer can actually bill. None of this is a reason not to sell; all of it is the reason the first advisor hired for a medical practice sale should be healthcare transaction counsel, before the letter of intent rather than after.

The physician's preparation list

The familiar program, with clinical specifics: build provider capacity so production survives your reduced role, run an internal billing and compliance review before a buyer runs theirs, organize the practice's financials to diligence standard, and confirm the lease and equipment picture. Then do the personal math honestly, because institutional offers that require five more working years are asking a question about your life that no valuation answers.